H:/re/tevoven/NRPo1blDCC/REC/6027874_doc-!7/02/20H Substituted triazoles and pharmaceutical compositions containing the compounds are disclosed as being useful in -inhibiting the activity of the receptor protein tyrosine kinase AxI. Methods of using the compounds in treating diseases or conditions associated with Axn activity are also disclosed.